Russian medics announce about successful clinical studies of safety and pharmacokinetics of an innovative anti-AIDS treatment VM-500.

      First phase of clinical trials consisted of testing the drug on a group of 24 volunteers. Healthy people took the drug orally, and experiment showed that the treating agent didn’t harm volunteers’ health and was well tolerated by them without any serious adverse events detected.

      Next stage of the trials will be performed with participation of HIV-positive volunteers, who never received any antiretroviral treatment. If gel with the drug appears to be effective against sexual transmission of the virus, African population will have a hope in their fight with AIDS.

      Source: Science & Technologies